LGMN and metastatic malignant neoplasm in the lymph nodes: Over-expression of Legumain was significantly associated with lymph node metastasis (P<0.001), peritoneal metastasis (P = 0.002), hepatic metastasis (P = 0.014) and histologic type (P = 0.095), the T stage (P = 0.003).